Drug Profile
Calcitriol - Abbott
Alternative Names: Calcijex; Dihydroxycholecalciferol - Abbott; Dihydroxyvitamin D3 - AbbottLatest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Class Antipsoriatics; Chemoprotectants; Dihydroxycholecalciferols; Osteoporosis therapies; Small molecules; Vitamin D analogues
- Mechanism of Action Vitamin D3 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Hyperparathyroidism; Hypocalcaemia; Hypoparathyroidism; Osteodystrophy
Most Recent Events
- 16 Jul 1999 A phase I trial in patients with advanced cancer has been added to the therapeutic trials, adverse events and pharmacokinetics sections
- 16 Jul 1999 Phase-I clinical trials for Cancer in USA (SC)
- 01 Jul 1999 A study comparing oral and intraperitoneal administration in children with secondary parathyroidism has been added to the therapeutic trials section